Unusual Immune Cell Type Could Be Good Target for Immunotherapy
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Dr. Katharine Hsu Named Director of Tri-Institutional M.D.-Ph.D. Program
In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.
In the Lab
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia
In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.